Gupta N - Search Results

1

Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency.

Gupta V, Gupta N, Shaik IH, Mehvar R, Nozik-Grayck E, McMurtry IF, Oka M, Komatsu M, Ahsan F. Gupta V, et al. Among authors: gupta n. Mol Pharm. 2013 May 6;10(5):1655-67. doi: 10.1021/mp300426u. Epub 2013 Mar 26. Mol Pharm. 2013. PMID: 23485062 Free PMC article.

2

Computational and bioengineered lungs as alternatives to whole animal, isolated organ, and cell-based lung models.

Patel B, Gauvin R, Absar S, Gupta V, Gupta N, Nahar K, Khademhosseini A, Ahsan F. Patel B, et al. Among authors: gupta n, gupta v. Am J Physiol Lung Cell Mol Physiol. 2012 Nov 1;303(9):L733-47. doi: 10.1152/ajplung.00076.2012. Epub 2012 Aug 10. Am J Physiol Lung Cell Mol Physiol. 2012. PMID: 22886505 Free article.

3

Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension.

Gupta V, Gupta N, Shaik IH, Mehvar R, McMurtry IF, Oka M, Nozik-Grayck E, Komatsu M, Ahsan F. Gupta V, et al. Among authors: gupta n. J Control Release. 2013 Apr 28;167(2):189-99. doi: 10.1016/j.jconrel.2013.01.011. Epub 2013 Jan 23. J Control Release. 2013. PMID: 23353807 Free PMC article.

4

In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals.

Nahar K, Gupta N, Gauvin R, Absar S, Patel B, Gupta V, Khademhosseini A, Ahsan F. Nahar K, et al. Among authors: gupta n, gupta v. Eur J Pharm Sci. 2013 Aug 16;49(5):805-18. doi: 10.1016/j.ejps.2013.06.004. Epub 2013 Jun 22. Eur J Pharm Sci. 2013. PMID: 23797056 Review.

5

Low-molecular-weight heparin (LMWH)-loaded large porous PEG-PLGA particles for the treatment of asthma.

Patel B, Gupta N, Ahsan F. Patel B, et al. Among authors: gupta n. J Aerosol Med Pulm Drug Deliv. 2014 Feb;27(1):12-20. doi: 10.1089/jamp.2013.1073. Epub 2013 Nov 28. J Aerosol Med Pulm Drug Deliv. 2014. PMID: 24286441 Free PMC article.

6

Nano-engineered erythrocyte ghosts as inhalational carriers for delivery of fasudil: preparation and characterization.

Gupta N, Patel B, Ahsan F. Gupta N, et al. Pharm Res. 2014 Jun;31(6):1553-65. doi: 10.1007/s11095-013-1261-7. Epub 2014 Jan 22. Pharm Res. 2014. PMID: 24449438 Free PMC article.

7

Aerosolized montelukast polymeric particles-an alternative to oral montelukast-alleviate symptoms of asthma in a rodent model.

Patel B, Gupta N, Ahsan F. Patel B, et al. Among authors: gupta n. Pharm Res. 2014 Nov;31(11):3095-105. doi: 10.1007/s11095-014-1402-7. Epub 2014 Jun 17. Pharm Res. 2014. PMID: 24934662

8

Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.

Gupta N, Ibrahim HM, Ahsan F. Gupta N, et al. J Pharm Sci. 2014 Nov;103(11):3743-3753. doi: 10.1002/jps.24193. Epub 2014 Sep 29. J Pharm Sci. 2014. PMID: 25266507 Free PMC article.

9

Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension.

Nahar K, Absar S, Gupta N, Kotamraju VR, McMurtry IF, Oka M, Komatsu M, Nozik-Grayck E, Ahsan F. Nahar K, et al. Among authors: gupta n. Mol Pharm. 2014 Dec 1;11(12):4374-84. doi: 10.1021/mp500456k. Epub 2014 Nov 4. Mol Pharm. 2014. PMID: 25333706 Free PMC article.

10

Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats.

Gupta N, Patel B, Nahar K, Ahsan F. Gupta N, et al. Eur J Pharm Biopharm. 2014 Nov;88(3):1046-55. doi: 10.1016/j.ejpb.2014.10.012. Eur J Pharm Biopharm. 2014. PMID: 25460151 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,635 results

Search Page

Filters